Access cutting-edge cholangiocarcinoma treatment through this clinical trial at a research site in Westwood%2c Los Angeles. Study-provided care at no cost to qualified participants.
Access cholangiocarcinoma specialists in Westwood%2c Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cholangiocarcinoma treatment provided free
This study is a Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician's Choice in Subjects with Fibroblast Growth Factor Receptor (FGFR)-altered, Chemotherapy- and FGFR Inhibitor-Refractory/Relapsed Cholangiocarcinoma
Sponsor: TransThera Sciences (Nanjing), Inc.
Check if you qualify for this cholangiocarcinoma clinical trial in Westwood%2c Los Angeles, CA
If you're searching for cholangiocarcinoma treatment options in Westwood%2c Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Westwood%2c Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cholangiocarcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.